VXA-G2-4-NS

N/A

Report date: 2022/11/28 20:03:56

Base Information

Drug NameVXA-G2-4-NS
Drug Alias NameMonovalent GII.4 tableted vaccine - VaxartNorovirus GII.4 vaccine - VaxartGII.4 oral vaccine tablet - VaxartVXA-G2-4-NSVXA-G2.4-NS
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNorovirus InfectionsCaliciviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Africa
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxart Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaxart Inc
Inactive CompaniesN/A
Active IndicationsNorovirus InfectionsCaliciviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A